Optimising anti-TNF treatment using biosimilars
Non-response or loss of response to anti-TNFs in IBD: what’s the cause?
Non-response or loss-of response to anti-TNFs in IBD: what’s the cause?
Why does anti-TNF treatment of IBD lose effectiveness in up to 50% of patients? Find out more about the background of this condition and what can be done to manage patients better with an infographic on recent research on anti-TNFs in IBD.
This content has been developed independently by Medthority who previously received educational funding in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.